» Articles » PMID: 24349377

Generation of Human Induced Pluripotent Stem Cells Using Epigenetic Regulators Reveals a Germ Cell-like Identity in Partially Reprogrammed Colonies

Overview
Journal PLoS One
Date 2013 Dec 19
PMID 24349377
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have shown that induced pluripotent stem cells (iPSCs) can be derived from fibroblasts by ectopic expression of four transcription factors, OCT4, SOX2, KLF4 and c-MYC using various methods. More recent studies have focused on identifying alternative approaches and factors that can be used to increase reprogramming efficiency of fibroblasts to pluripotency. Here, we use nucleofection, morpholino technologies and novel epigenetic factors, which were chosen based on their expression profile in human embryos, fibroblasts and undifferentiated/differentiated human embryonic stem cells (hESCs) and conventionally generated iPSCs, to reprogram human fibroblasts into iPSCs. By over expressing DNMT3B, AURKB, PRMT5 and/or silencing SETD7 in human fibroblasts with and without NANOG, hTERT and/or SV40 overexpression, we observed the formation of colonies resembling iPSCs that were positive for certain pluripotency markers, but exhibited minimal proliferation. More importantly, we also demonstrate that these partially-reprogrammed colonies express high levels of early to mid germ cell-specific genes regardless of the transfection approach, which suggests conversion to a germ cell-like identity is associated with early reprogramming. These findings may provide an additional means to evaluate human germ cell differentiation in vitro, particularly in the context of pluripotent stem cell-derived germ cell development, and contribute to our understanding of the epigenetic requirements of the reprogramming process.

Citing Articles

Lysine-specific methyltransferase Set7/9 in stemness, differentiation, and development.

Daks A, Parfenyev S, Shuvalov O, Fedorova O, Nazarov A, Melino G Biol Direct. 2024; 19(1):41.

PMID: 38812048 PMC: 11137904. DOI: 10.1186/s13062-024-00484-z.


Nucleic acid direct delivery to fibroblasts: a review of nucleofection and applications.

Ren R, Guo J, Liu G, Kang H, Machens H, Schilling A J Biol Eng. 2022; 16(1):30.

PMID: 36329479 PMC: 9635183. DOI: 10.1186/s13036-022-00309-5.


PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression.

Chiang K, Zielinska A, Shaaban A, Sanchez-Bailon M, Jarrold J, Clarke T Cell Rep. 2017; 21(12):3498-3513.

PMID: 29262329 PMC: 5746596. DOI: 10.1016/j.celrep.2017.11.096.


Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency.

Munoz-Lopez A, Romero-Moya D, Prieto C, Ramos-Mejia V, Agraz-Doblas A, Varela I Stem Cell Reports. 2016; 7(4):602-618.

PMID: 27666791 PMC: 5063541. DOI: 10.1016/j.stemcr.2016.08.013.

References
1.
Agger K, Cloos P, Christensen J, Pasini D, Rose S, Rappsilber J . UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature. 2007; 449(7163):731-4. DOI: 10.1038/nature06145. View

2.
Nazor K, Altun G, Lynch C, Tran H, Harness J, Slavin I . Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell. 2012; 10(5):620-34. PMC: 3348513. DOI: 10.1016/j.stem.2012.02.013. View

3.
Polo J, Anderssen E, Walsh R, Schwarz B, Nefzger C, Lim S . A molecular roadmap of reprogramming somatic cells into iPS cells. Cell. 2012; 151(7):1617-32. PMC: 3608203. DOI: 10.1016/j.cell.2012.11.039. View

4.
Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin I . Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009; 324(5928):797-801. PMC: 2758053. DOI: 10.1126/science.1172482. View

5.
Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T . Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2007; 26(1):101-6. DOI: 10.1038/nbt1374. View